Bufei huoxue capsules in the management of convalescent COVID‐19 infection: study protocol for a multicenter, double‐blind, and randomized controlled trial

Up to 30 May 2021, the cumulative number of patients diagnosed with corona virus disease‐19 (COVID‐19) globally has exceeded 170 million, with more than 152 million patients recovered from COVID‐19. However, the long‐term effect of the virus infection on the human body’s function is unknown for conv...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yuqin Chen, Wenjun He, Wenju Lu, Yue Xing, Jianling Bai, Hao Yu, Jiawei Zhou, Jingyi Liang, Jiyuan Chen, Chi Hou, Bihua Zhong, Ting Wang, Huazhuo Feng, Xu Chen, Tao Wang, Kai Yang, Nuofu Zhang, Nanshan Zhong, Chunli Liu, Jian Wang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2021-07-01
Series:	Pulmonary Circulation
Assuntos:	Bufei Huoxue capsules novel coronavirus 2019 recovery period randomized controlled trial
Acceso en liña:	https://doi.org/10.1177/20458940211032125
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!